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Abstract The transmembrane glycoprotein CD38 is a bifunc- 
tional enzyme that catalyzes at its ectocellular domain both the 
synthesis and the hydrolysis of cyclic ADP-ribose (cADPR). The 
complete reaction, converting NAD + to nicotinamide and ADP- 
ribose, reproduces an NAD+glycohydrolase (NADase) reaction. 
CD38 purified from human erythrocyte membranes has been 
recently shown to undergo stable oHgomerization induced by 
either NAD ÷ or /l-mercaptoethanol. We demonstrate that oli- 
gomerization is also triggered by reduced glutathione (GSH) and 
that the GSH-induced self-aggregation of purified CD38 is ac- 
companied by extensive and comparable decrease of its ADP- 
ribosyl cyclase and NADase activities. GSH-induced oligomeri- 
zation of CD38 and strong enzyme inactivation take place also 
in situ on erythrocyte membranes. 
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I. Introduction 
Human CD38, a type II transmembrane glycoprotein of 46 
kDa predominantly expressed on the activated phenotypes of 
mononuclear nd lymphocyte cell types [1-3], has been recently 
shown to be a bifunctional enzyme catalyzing both the synthe- 
sis of cyclic ADP-ribose (cADPR) from NAD ÷ and the hydrol- 
ysis of cADPR to ADP-ribose (ADPR) [4-8]. The two enzyme 
activities are located at the ectocellular, C-terminal region of 
CD3814-6] and are defined as ADP-ribosyl cyclase (cyclase) 
and cADPR hydrolase (hydrolase). The combination of these 
two activities reproduces an apparent NAD ÷ glycohydrolase 
(NADase) reaction and it is likely that several known NADases 
are, in fact, ADP-ribosyl cyclases [9]. 
CD38 is believed to be involved in the reception/transduction 
processes of signals eliciting the activation and proliferation of 
lymphoid cells [1]. The observation that 'agonistic' monoclonal 
antibodies (MoAbs), reactive against he ectocellular domain 
of CD38, stimulate the proliferation of CD38 ÷ve T and B lym- 
phocytes [3], strongly supports this notion. However, it is not 
known whether the mechanisms of these cellular processes are 
related to cADPR formation. This NAD* metabolite isa potent 
Ca2÷-mobilizer from intracellular stores both in invertebrate as 
well as in vertebrate cells [10-13] and perturbations of intracel- 
lular Ca 2+ concentrations are known to be implicated in several 
mechanisms of cell activation/proliferation. The ectoenzymatic 
nature of CD38, however, poses a topological obstacle to the 
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possible involvement of extracellularly produced cADPR in 
intracellular Ca 2÷ mobilization [12]. 
We have recently demonstrated that human CD38, purified 
to homogeneity from erythrocyte membranes, undergoes a sta- 
ble self-aggregation when is incubated with its substrate NAD ÷ 
and/or ~-mercaptoethanol [14]. Since receptor dimerization or 
oligomerization upon interaction with specific ligands is a 
widely known pre-requisite for subsequent internalization 
[15,16], susceptibility of CD38 to self-aggregation might repre- 
sent a means for its intracellular import and metabolism of 
cADPR. Therefore, we investigated (a) the relationship be- 
tween CD38 self-aggregation a d levels of its intrinsic cyclase 
activity, (b) the occurrence of CD38 oligomerization within 
human erythrocyte ghosts taken as a model of cell membrane. 
Red cell ghosts are more suitable than lymphocyte membranes 
to study the enzyme activities of CD38 because, although CD38 
has a much lower density on erythrocyte than on lymphocyte 
membranes, no other enzyme activities degrading NAD ÷ or 
ADPR are present on the erythrocyte membrane [17]. The 
results reported in this paper indicate that oligomerization is 
paralleled by extensive nzyme inactivation, both with purified 
and with membrane-bound CD38. 
2. Materials and methods 
2.1. Materials 
[32p]Adenylate NAD ÷ was purchased from NEN, Italy, and purified 
by HPLC on a PL SAX 1000, 50x5 mm anion exchange column (Hewl- 
ett Packard) as follows: solvent A was distilled water; solvent Bwas 0.15 
M TFA; the solvent program was a gradient starting at 100% A, linearly 
increasing to 15% B in 20 min, then linearly increasing to 100% B in 
10 min, at a flow rate of 0.5 ml/min. 
Standard cyclic ADP-ribose and ADP-ribosyl cyclase purified from 
Aplysia californica ovotestis were kindly provided by Prof. H.C. Lee, 
Minneapolis, MN. Anti-CD38 monoclonal ntibody IB4 [18] was a 
generous gift by Prof. F. Malavasi, Turin, Italy. CD38 was purified 
from solubilized erythrocyte membranes as described in [5]. White 
erythrocyte ghosts were prepared from freshly drawn human citrated 
blood, after removal of leukocytes and platelets, as described [17]. 
Nitrocellulose sheets (0.45/~m) for Western blotting and the peroxi- 
dase-conjugated anti-mouse Ig kit for immunoenzymatic detection of 
CD38 were obtained from BioRad, Italy. ~2SI-Labelled sheep anti- 
mouse Ig antibody was purchased from Amersham, Italy. 
2.2. Fluorimetric detection of cyclic GDP-ribose (cGDPR) production 
The assay was performed essentially as in [9] in a Perkin Elmer model 
LS 50 B luminescence spectrometer at 37°C under continuous stirring. 
Production of cGDPR from nicotinamide guanine dinucleotide (NGD) 
by purified CD38 was monitored continuously at 410 nm emission 
wavelength (excitation at 300 nm). 
2.3. SDS-PAGE 
Purified CD38 (0.2/tg) or white erythrocyte membranes (60/lg) were 
subjected to SDS-PAGE on 7-12% gradient gels according to [19]. 
Western blot was performed according to [20] for 3 h at 2°C on 
0014-5793195/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSD1 0014-5793(95)00005-4 
36 E. Zocchi et al./FEBS Letters 359 (1995) 35~I0 
0.45 ¢tm nitrocellulose membranes. Saturation of nitrocellulose with 
gelatin and incubation with the anti-CD38 MoAb [18] were performed 
following instructions of the BioRad immunoperoxidase assay kit. Im- 
munodetection f the CD38 protein band was obtained with a peroxi- 
dase-conjugated (BioRad) or a 125I-labelled (Amersham) anti-mouse 
antibody for the purified CD38 and the erythrocyte membranes, respec- 
tively. 
2.4. Quantitation f[32p]ADPR and [32p]cADPR produced from 
[32p]NAD + by purified CD38 
Purified CD38 was incubated with [32p]NAD +, under the conditions 
described in the legend to Fig. 3, and TCA extracts at the various times 
were analyzed on a 3/.tm, 60×4.6 mm, ODS Hypersil C~8 reverse phase 
column (Hewlett Packard) with the following analysis: solvent A was 
distilled water; solvent B was 0.1 M KH2PO4 containing 5 mM Pic A 
reagent (Millipore, Italy) and 30% methanol, with the pH adjusted to 
5.0. The solvent program used (at a flow rate of 0.5 ml/min) was a 
gradient starting at 100% solvent A for 5 min, then linearly increasing 
to 10% B in 15 min, then linearly increasing to 80% B in 30 min. This 
analysis allows a good separation of [32p]cADPR not only from 
[32p]NAD* and [32p]ADPR, but also from the trace amounts of [32p]or- 
thophosphate hat remain after HPLC purification of [32p]NAD ÷ (see 
above). 
The specific activity of [32p]NAD÷ (105 cpm/nmol) was calculated 
from the integrated area (Hewlett Packard 79996A analytical worksta- 
tion) and the radioactivity of the NAD + peak at zero time. 
2.5. Assay of NADase and ADP-ribosyl cyclase activities of erythrocyte 
membranes 
Following pre-incubation with or without GSH, as described in the 
legend to Fig. 4, aliquots were withdrawn at different imes and mem- 
branes washed in 10 mM Tris-HC1, pH 6.5, resuspended in the same 
buffer at 1.5 mg/ml and incubated further at 37°C in the presence of 
1 mM NAD ÷. At zero time and after 15 and 30 min incubation, aliquots 
were withdrawn, briefly centrifuged to remove the membranes and the 
supernatants immediately frozen at -20°C. The NAD ÷, ADPR and 
cADPR concentrations in the supernatants were determined by HPLC 
analysis as in [5]. 
2.6. A cetylcholinesterase (Achase) activity of erythrocyte membranes 
This was determined as in [21]. 
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Fig. 1. Transmission electron microscopy and immunoblotting of purified CD38 incubated with GSH. Purified CD38 (0.2 pg) was incubated at 37 ° C 
in the absence (control) or presence of 25 mM GSH. After 60 min incubation, the mixtures were divided in two parts. One part was spotted onto 
a grid, negatively stained with 1% sodium silicotungstate and analyzed by transmission electron microscopy at a 150,000-fold magnification (see [ 14] 
for details). (A) Control. (B) GSH-incubated CD38. Bar = 50 nm. The other part of each mixture was subjected to SDS-PAGE and Western blot. 
Immunoenzymatic detection was performed as described in section 2. (C) Lane 1, control; lane 2, GSH-incubated CD38. 
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Fig. 2. Production ofcGDPR by purified CD38 in the absence or presence of GSH and Western blot analysis of the protein before and after incubation. 
Purified CD38 (0.2/~g per assay) was incubated at 37°C in a fluorimetric uvette in 2 ml of 2 mM Tris-HCl, pH 6.5, 0.01% Triton X-100 and 25 
mM NGD (buffer), under continuous tirring. The trace shows the production of cGDPR (see section 2). The arrow indicates addition of 100/11 
buffer (B) or 100/~1 0.5 M GSH (C). At zero time and after 60 min incubation with or without GSH, the samples were rapidly frozen, lyophilized 
and subjected to SDS-PAGE and Western blot. Immunoenzymatic detection of CD38 was carried out as described in section 2. Inset: (A) zero time; 
(B) 60 rain incubation with NGD; (C) 60 min incubation with NGD and GSH. Result from a representative experiment are shown for the sake of 
clarity. Variability in five different experiments never exceeded 9%. 
3.  Resu l ts  
In a previous paper, we demonstrated that purified human 
CD38 undergoes elf-aggregation upon incubation with NAD + 
and/or f l -mercaptoethanol (f -ME) [14]. Evidence for protein 
aggregation was obtained by two different approaches: (a) dis- 
appearance of the monomeric 46 kDa protein band detectable 
by SDS-PAGE, due to formation of large aggregates unable to 
38 E. Zocchi et al./FEBS Letters 359 (1995) 35~t0 
I000 
i00 
i0 _~---~ ~ --~ 
B 
0 
t~ 
0 
0 
I I 1 I 
15 30 45 60 
Incubation t ime (min) 
Fig. 3. Production of ADP-ribose from NAD ÷ by either native or 
GSH-preincubated purified CD38. Purified CD38 (30 ng) was incu- 
bated in 20/11 of 5 mM Tris-HCl, pH 6.5, 0.05% Triton X-100, without 
(A) or with (B) 0.2 mM GSH. After 45 min at 37°C a sample of each 
incubation was diluted 104 times in the same, homologous buffer and 
200/,tl aliquots further incubated in the presence of0.2 mM GSH and 
0.1 mM [32p]NAD (105 cproJnmol). At the times indicated, aliquots were 
withdrawn, TCA (10%, final concentration) was added to stop the 
reaction together with 10 pmol standard, unlabelled cADPR, the TCA 
extracted with ether and samples were subjected toHPLC analysis as 
described in section 2. Fractions were collected every 30 s and the 
radioactivity co-eluting with the ADPR and cADPR peaks was 
counted. For the sake of clarity, only the NADase activity of both 
incubation mixtures i shown. Cyclase activity was approximately l/100 
of the value of the NADase at each time point. Results of a representa- 
tive experiment are shown, out of four different ones in which variabil- 
ity never exceeded 13%. 
enter the stacking el, and (b) transmission electron microscopy 
of negatively stained incubation samples [14]. 
Subsequent experiments demonstrated that the concentra- 
tions ofNAD + andfl-ME could be decreased to 10pM without 
impairing the oligomerization process (not shown). In addition, 
reduced glutathione (GSH) was found to be as powerful as 
fl-ME in inducing CD38 self-aggregation, as shown both by 
electron microscopy and by SDS-PAGE followed by im- 
munoblotting (Fig. 1). 
In order to follow the cyclase activity of CD38 during the 
process of GSH-induced aggregation, we took advantage of a 
recently described fluorimetric assay for the detection of 
cyclase activity. This assay is based on the fluorescent proper- 
ties of cyclic GDP-ribose (cGDPR), which is produced from the 
non-fluorescent NGD by Aplysia cyclase, as well as by human 
recombinant CD38 [9]. Moreover, cGDPR, unlike cADPR, is 
a very poor substrate for the hydrolase activity of CD38 [9], and 
GDPR is not fluorescent: hus, the fluorimetric detection of 
cGDPR production from NGD represents a convenient assay 
for determination f the cyclase activity only. 
When purified CD38 was incubated with NGD at 37°C, the 
rate of production of cGDPR, as determined by its fluorescence 
emission at 410 nm, was almost linear (Fig. 2, curve B): the 
slope of the curve after 60 min incubation was 80% of that 
recorded uring the first minutes after addition of substrate. On 
the other hand, upon addition of 25 mM GSH, the rate of 
cGDPR production decreased progressively (Fig. 2, trace C) 
and after 60 min the cyclase activity was reduced to 10% of the 
control. 
In parallel experiments, performed on the cyclase from Aply- 
sia califbrnica [22], GSH had no effect on the production of 
cGDPR (not shown). This rules out any quenching of the 
cGDPR fluorescence by GSH and any inactivation of the 
cyclase. 
In the same experiment illustrated in Fig. 2, immunoblot 
analyses of CD38 were carried out on samples withdrawn be- 
fore and after incubation with or without GSH. As shown in 
Fig. 2 (inset), a 46 kDa band was present at zero time (A) and 
its intensity was comparable after 60 min incubation with NGD 
(B), in agreement with the limited decay of the cyclase activity. 
No 46 kDa band was detectable after 60 min incubation with 
NGD and GSH (C), indicating that, concomitant with extensive 
cyclase inactivation, all CD38 had aggregated (see also Fig. 1). 
The experiment shown in Fig. 2 cannot be performed with 
NAD ÷ as substrate, because cADPR is not fluorescent, nor 
with a mixture of NGD and NAD ÷ as substrates, because a
decreased rate of cGDPR production might be due to competi- 
tion between the two substrates for the enzyme's active site [9] 
rather than to CD38 oligomerization. Therefore, an alternative 
approach was followed. Purified CD38 was pre-incubated for 
45 min with or without GSH, i.e. under conditions resulting in 
oligomerization or maintenance of the 46 kDa monomeric 
form, respectively. Both samples were then diluted l0  4 times 
and their rates of NADase and cyclase activities were deter- 
mined using NAD + as substrate. The protein concentration in 
this assay was kept very low (3 pM) in order to prevent CD38 
from aggregating too fast during the assay, i.e. in the presence 
of NAD ÷. As shown in Fig. 3, in the pre-aggregated sample (B), 
the rates of NADase and cyclase activities were constant at 1% 
approximately of the starting level observed with monomeric 
CD38 (A). On the contrary, the enzyme activities of sample A 
decreased markedly (100 times) during the first 20 min incuba- 
tion and remained constant thereafter (30 60 min), at about he 
same value as in the pre-aggregated sample. 
These results indicate that the intrinsic NADase and cyclase 
activities of oligomerized CD38 are around 1% of those dis- 
played by monomeric CD38. Conversion of the monomeric to 
the aggregated species, occurring during the assay itself because 
of the presence of GSH and NAD ÷, is accompanied by a con- 
comitant and progressive drop of enzyme activities, i.e. from 
100% to 1%. 
Finally, we investigated if aggregation of CD38 and enzyme 
inactivation could take place also in situ on erythrocyte mem- 
branes in the presence of GSH. Thus, erythrocyte membranes 
were incubated at 37°C in the absence or presence of 25 mM 
GSH, and NADase and ADP-ribosyl cyclase activities were 
determined atvarious times of incubation. 
Results of a typical experiment are shown in Fig. 4. While 
CD38 enzyme activities kept constant during incubation with- 
out GSH (Fig. 4, curve A), a marked decay of both NADase 
and cyclase activities was observed in the membranes incubated 
with GSH: after 24 h, levels as low as 4% and 5% of the 
activities measured at zero time were observed, respectively 
(Fig. 4, curve B). Western blot analysis of the membranes at the 
end of the 24 h incubation revealed that the CD38 46 kDa band 
was present in the control membranes (Fig. 4, inset, A) while 
it had disappeared from the GSH-incubated membranes (Fig. 
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Fig. 4. NADase and ADP-ribosyl cyclase activities of erythrocyte membranes incubated with GSH. Hemoglobin-free rythrocyte ghosts (3 mg/ml) 
were incubated at 37°C in 10 mM Tris-HC1, pH 6.5, in the absence (A) or presence (B) of 25 mM GSH. At the times indicated, aliquots from the 
incubation mixtures were withdrawn, the membranes washed three times with saline, and NADase (circles), ADP-ribosyl cyclase (triangles) and 
Achase activities were determined as in section 2. The mean values from three different experiments are shown: variability never exceeded 6% for 
each time point. After 24 h the membranes from either incubation mixture were washed and 60 pg were subjected to SDS-PAGE, Western blot and 
radioimmunodetection of CD38 as in section 2. The result of a representative experiment is shown in the inset. 
4, inset, B). Acetylcholinesterase activity of both control and 
GSH-treated membranes, measured as a reference nzyme, re- 
mained constant hroughout the 24-h incubation (not shown). 
4. Discussion 
The purpose of this study was two-fold: (a) to determine if
aggregation of CD38 had any effect on its enzymatic activities, 
particularly on the ADP-ribosyl cyclase activity; and (b) to 
investigate whether oligomerization could also take place on 
the erythrocyte membrane. The present findings demonstrate 
that the GSH-induced aggregation of purified CD38 is accom- 
panied by extensive loss of its cyclase activity, assayed with 
either NGD or NAD ÷ as substrate. Specifically, the cyclase 
activity decreased 10 times (with NGD as substrate, Fig. 2) or 
100 times (with NAD ÷ as substrate, Fig. 3) following addition 
of GSH. This discrepancy is most likely due to the fact that 
NAD ÷ itself is also an efficient inducer of CD38 aggregation 
[14], while NGD is not (Fig. 2, inset). The apparent NADase 
activity was also markedly decreased to a comparable xtent 
following aggregation. It is still uncertain whether NADase 
activity is an intrinsic and cyclase-independent property of 
CD38 or rather epresents he sum of the cyclase and hydrolase 
activities. Recent kinetic data obtained with NGD as substrate 
seem to support the second hypothesis [9], which is also fa- 
voured by the following observations: a) throughout the proc- 
ess of GSH-induced aggregation the ratio between NADase 
and cyclase activities of CD38 remained constant and, b) aggre- 
gation induced a comparable decay ofcADPR hydrolase activ- 
ity (Guida, L., unpublished ata). 
The results shown in Fig. 4 also demonstrate hat aggrega- 
tion of CD38, and the consequent decrease of enzyme activities, 
can occur in situ on erythrocyte membranes. The process of 
aggregation is apparently much slower on the membranes as 
compared to the free protein in solution, taking hours rather 
than minutes. This difference could be explained by the mobil- 
ity restrictions imposed on the transmembrane CD38 protein 
by the lipid bilayer and possibly by cytoskeletal and integral 
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membrane proteins as well. It may be relevant o this purpose 
that in other CD38 ÷ve cells like T, B and NK lymphocytes, 
CD38 is physically and functionally associated with specific 
surface receptors [18]. 
As mentioned, this study was carried out with human eryth- 
rocyte CD38 because: (a) the red cell membrane lacks other 
NAD+-degrading enzymes that might interfere with assays of 
cyclase and NADase activities [17]; and (b) in vitro oligomeriza- 
tion had been observed with the glycoprotein purified from red 
cell membranes [14]. It is likely that in situ self-aggregation a d 
concomitant enzyme inactivation also take place in the mem- 
brane from other CD38 +ve cells, notably lymphocytes. Some 
pathophysiological events, like apoptosis in lymphnodes or ex- 
tensive cell death, might lead to local increases of extracellular 
GSH and NAD ÷ concentrations up to levels (around 10/tM) 
that are sufficient o trigger self-aggregation f CD38. 
In conclusion, self-aggregation f CD38 seems to be an in- 
trinsic property of this glycoprotein, both purified and mem- 
brane-bound. However, the role of such oligomerization and 
specifically its relationship with CD38-related cellular proc- 
esses, like activation and proliferation, is still completely un- 
known. The concomitant marked decay of the cyclase activity 
might suggest hat CD38 oligomerization represents a mecha- 
nism designed to down-regulate cADPR-dependent events. 
Identification of these events and their correlation with CD38 
properties, particularly in situ self-aggregation, will be the sub- 
ject of future research. 
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